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Edited by Beat ImhofAbstract Hepatocyte growth factor (HGF) mediates cancer
cell invasion and metastasis. This study characterised the
down-regulation of HGF expression by pyrrolidine dithiocarba-
mate (PDTC), which markedly reduced HGF mRNA expression
and protein production in MRC-5 cells. Reporter gene studies re-
vealed that PDTC inhibited HGF gene transcription and that the
response element is located in the region 75 to +42 bp ﬂanking
the transcription initiation site. Electrophoretic mobility shift as-
say identiﬁed three speciﬁc protein complexes binding in this re-
gion, which were abrogated by exposure of cells to PDTC.
PDTC deserves further investigation as a novel therapeutic agent
for HGF-driven cancers.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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stability1. Introduction
Hepatocyte growth factor (HGF) is produced by mesenchy-
mal cells and stimulates cell proliferation, motility and mor-
phogenesis in epithelial cells, depending on the target cell
and culture conditions [1,2]. Due to its ability to co-ordinate
cell proliferation, migration and matrix remodelling, HGF is
an important physiological regulator in embryological devel-
opment [3,4] and has a vital role in the generation and mainte-
nance of normal organ complexity and architecture [5]. Cancer
cell growth is an aberrant counterpart of physiological mor-
phogenic growth and HGF is one of the factors stimulating
cancer cells to invade locally and to metastasize [6].
The HGF receptor, MET, was originally identiﬁed as the
product of the oncogene, TPR–MET [7]. Although mutant
versions of MET show enhanced signalling, they still require
ligand binding to cause cell transformation [8] and HGF has
been found to stimulate growth, motility and invasiveness in
a number of tumour cell lines [9,10]. The blockade of HGF–Abbreviations: HGF, hepatocyte growth factor; PDTC, pyrrolidine
dithiocarbamate; FCS, foetal calf serum; BS, bovine serum; PMA,
phorbol 12-myristate 13-acetate; CAT, chloramphenicol acetyl trans-
ferase; EMSA, electrophoretic mobility shift assay; IL-1b, interleukin
1 beta; NAC, N-acetylcysteine
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doi:10.1016/j.febslet.2008.04.055MET signalling using a hammerhead ribozyme [11], or neutral-
izing antibodies against MET [12] or HGF [13], substantially
reduced the growth of U-87 cells in nude mice. These ﬁndings
indicate that HGF availability is crucial for MET-dependent
cell growth. Accordingly, inhibitors of HGF production could
have clinical application but surprisingly few have been de-
scribed. Previously, we demonstrated that transforming
growth factor-beta inhibits HGF gene expression by reducing
HGF mRNA stability [14], and although retinoids [15], gluco-
corticoids [16] and angiotensin II [17] have all been shown to
inhibit secretion of HGF, the mechanisms are unknown.
We previously reported that the antioxidant N-acetylcyste-
ine (NAC) increases HGF mRNA expression in MRC-5 cells
at the transcriptional level by a mechanism independent of
its ability to replete glutathione levels [18]. Pyrrolidine dithio-
carbamate (PDTC) is a water soluble, small molecule that is
commonly regarded as an antioxidant but it can also bind
and transport copper and zinc ions, and is known to modulate
several intracellular signalling pathways [19]. Whilst, in some
situations NAC and PDTC regulate gene transcription via
the same mechanism [20,21], the two compounds have been re-
ported to have antagonistic eﬀects [22,23]. In the present study,
we investigate the regulation of HGF expression in MRC-5
cells by PDTC. We demonstrate that rather than increase
HGF expression, PDTC is a potent inhibitor of HGF gene
transcription leading to a marked reduction in HGF mRNA
expression and protein production.2. Materials and methods
2.1. Materials
Foetal calf serum (FCS), bovine serum (BS), actinomycin D, NAC,
pyrrolidine dithiocarbamate (PDTC) and phorbol 12-myristate 13-ace-
tate (PMA) were from Sigma Chemical Company, Poole, UK; and the
32P-adATP and 14C-chloramphenicol were from ICN Flow, UK.
2.2. Culture of cell lines
Human embryonic lung ﬁbroblasts (MRC-5 cells) and mouse em-
bryo ﬁbroblasts (NIH3T3), obtained from the European collection
of animal cell cultures, were cultured in of Dulbeccos modiﬁed Eagle
medium with antibiotics (50 units/ml penicillin and 50 lg/ml strepto-
mycin) and 10% FCS or 10% BS, respectively.
2.3. Northern blot analysis
Total RNA was isolated according to the method described by
Chomczynski and Sacchi [24]. Each test condition was performed in
triplicate and the RNA pooled. RNA samples (30 lg) were fraction-
ated by gel electrophoresis (1% agarose and 2.2% formaldehyde) and
transferred to Genescreen (Du-Pont-NEN, Boston, USA) in 10·
SSC (1.5 M sodium chloride + 0.15 M trisodium citrate, pH 7.0).blished by Elsevier B.V. All rights reserved.
1860 P.M. Harrison, F. Farzaneh / FEBS Letters 582 (2008) 1859–1864Northern hybridisation was performed as previously described [14]
using a 32P-labelled 668 bp partial cDNA of HGF as a probe. The
membrane was exposed to X-ray ﬁlm with intensifying screens at
70 C; it was then stripped and rehybridised to a 32P-labelled
360 bp partial cDNA probe for GAPDH before being re-imaged.
The synthesis of the partial cDNA probes for HGF and GAPDH
has been described previously [14].
2.4. ELISA and scatter factor assay for HGF protein
MRC-5 cells were grown in 24-well plates to near conﬂuence, under
the same conditions as for the Northern blot analysis, and then ex-
posed to fresh media containing increasing concentrations of PDTC
for 3 days. Experiments were performed in triplicate and HGF levels
in MRC-5 cell conditioned media were measured by both ELISA
(R&D Systems, Abingdon, UK) and scatter factor assay, as described
previously [25].
2.5. HGF gene promoter activity
Construction of the HGF-chloramphenicol acetyl transferase (CAT)
chimeric reporter genes has been described previously [14]. NIH3T3
cells at 50–60% conﬂuence were transfected with 10 lg of HGF-CAT
chimeric plasmid and 2 lg of pSV-b-galactosidase control plasmid
(Promega, Madison, USA) using the calcium phosphate method [26]
and exposed to 500 lM PDTC for 24 h. The cells were harvested
and disrupted by three cycles of freeze–thaw. Aliquots of supernatant
were taken for both b-galactosidase and CAT activity; the latter were
heated to 60 C for 10 min to inactivate any endogenous acetylase and
deacetylase activity. All extracts were stored at 70 C. The b-galacto-
sidase activity was quantiﬁed according to the manufacturers instruc-
tions (Promega, Madison, USA) in order to assess transfection
eﬃciency, and the volume of supernatant assayed for CAT activity ad-
justed accordingly. CAT activity was measured according to the man-
ufacturers instructions, as described previously [14].2.6. Electrophoretic mobility shift assay (EMSA)
MRC-5 cells, grown to near conﬂuence, were scraped with a rubber
policeman and pelleted by centrifugation. The cells were washed in
1 ml Tris-buﬀered saline and pelleted again by centrifugation at 4 C.
All further steps were carried out at 4 C, on ice. The cells were resus-
pended in 0.4 ml of 10 mM Hepes, pH 7.8, 1 mM KCl, 2 mM MgCl2,
0.1 mM EDTA, 0.1 mM DTT, 0.1 mM PMSF and incubated for
15 min. The cells were lysed in 25 ll of Nonidet-P40 (10%, v/v) and
the nuclei pelleted before being resuspended in 50 ll 50 mM Hepes,
pH 7.8, 50 mM KCl, 300 mM NaCl, 0.1 mM EDTA, 1 mM DTT,
0.1 mM PMSF and 10% glycerol. After 20 min the extract was centri-
fuged again and the supernatant stored in aliquots at 70 C. Nuclear
protein concentrations were measured by BCA Protein Assay (Sigma,
UK), following the manufacturers instructions.
The 75 to +42 bp HGF promoter sequence, labelled with c32P-
dATP using T4 Polynucleotide Kinase for 1 h at 37 C, was used as
the DNA probe. The binding buﬀer, which was kept on ice, consisted
of 300 lg/ml bovine serum albumin (BSA), 1 ll poly(dI-dC) Æ poly(dI-
dC), 2 lg nuclear protein extract and 100-fold molar excess of the unla-
belled competitor probe if required, in a ﬁnal volume of 15 ll. After
addition of the labelled probe, the reactions were incubated on ice
for 30 min. The unlabelled, double-stranded competitor probes used
were: the 75 to +42 HGF sequence; a control designated E3, 5 0-
GATCGGTCATGTGGCAAGGCTATTTGGG-30, which has no
homology with HGF; and a control designated AP-1, 5 0-
CGCTTGATGACTCAGCCGGAA-3 0, which contains an activator
protein 1 consensus binding site. The DNA/protein complexes were re-
solved on a 6% polyacrylamide gel [1· Tris glycine buﬀer, 6% Accugel
(v/v), 2.5% glycerol (v/v)] electrophoresed at 40 mA for 3 h at 4 C. The
gel was dried and exposed to X-ray ﬁlm with intensifying screens at
70 C.3. Results
3.1. The eﬀect of PDTC on HGF expression in MRC-5 cells
MRC-5 cells were cultured in the presence of PDTC, RNA
was extracted and analyzed by Northern hybridization usinga 668 bp partial cDNA HGF probe, corresponding to exons
6–11 [18]. PDTC profoundly reduced the expression of all
HGF mRNA transcripts, in a dose- and time-dependent fash-
ion (Fig. 1a). To determine whether PDTC modulates induced
as well as innate HGF mRNA expression, we examined the ef-
fect of PDTC on the up-regulation of HGF mRNA in MRC-5
cells by PMA, a protein kinase C activator [27], by human
interleukin 1 beta (IL-1b) [28] or by the thiol NAC [18].
HGF mRNA was up-regulated in MRC-5 cells cultured for
24 h in increasing concentrations of PMA, IL-1b (Fig. 1b),
or NAC (Fig. 1c) but concomitant exposure to 500 lM PDTC
inhibited this increase.
To determine whether PDTC increased HGF RNA degrada-
tion, we assessed the half-life of the 6.0 kb HGFmRNA by har-
vesting RNA at time points after the addition of 5 lg/ml
actinomycin-D to sub-conﬂuent MRC-5 cells. HGF mRNA
levels were analyzed by Northern hybridization (Fig. 1d). The
half-life of the 6.0 kb HGF mRNA transcript was around 3 h
and was unaﬀected by exposure to 500 lMPDTC for 6 h, dem-
onstrating that PDTC has no eﬀect on HGF mRNA stability.
To look at the eﬀect of PDTC on HGF protein production,
HGF levels were measured in MRC-5 cell conditioned media
by both immunological assay (ELISA) and the functional scat-
ter factor assay [25]. Exposure to PDTC for 3 days markedly
reduced HGF protein production (Fig. 1e).3.2. PDTC inhibits HGF gene transcription
The transcriptional activity of the HGF-CAT constructs
demonstrates that the HGF promoter region is highly regu-
lated (Fig. 2a). There are inhibitory regions between 715 to
491 and 375 to 75 bp and an up-regulatory region be-
tween 491 and 375 bp. The smallest construct, 75HGF-
CAT, which contains a potential mammalian C-type LTR
TATA box localized at 38 to 20 [29], had the highest tran-
scriptional activity. The activity of the 906HGF-CAT,
715HGF-CAT, 491HGF-CAT, 375HGF-CAT and 75HGF-
CAT constructs was reduced by exposure to 500 lM PDTC
for 24 h to 23%, 21%, 14%, 15% and 22% of baseline values,
respectively (Fig. 2a). These results indicate that the main re-
sponse element mediating the eﬀect of PDTC on HGF gene
transcription is located between 75 and +42 bp in the 5 0-
ﬂanking region.3.3. PDTC mediates nuclear protein binding to the HGF gene
between 75 and +42 bp
EMSA was used to resolve the binding of nuclear proteins to
the region of the HGF gene, between 75 and +42 bp. Nuclear
protein in control MRC-5 cells produced three speciﬁc binding
complexes with a 32P-labelled, double-stranded, 75 to +42 bp
HGF DNA probe (Fig. 2b). These DNA/protein binding com-
plexes were lost following the addition of an excess of unla-
beled HGF DNA probe but were unaﬀected by an excess of
either AP-1 or E3 control probes. The speciﬁc DNA/protein
binding complexes were also lost when EMSA was performed
using nuclear protein extracted from MRC-5 cells that had
been exposed to 500 lM PDTC for 24 h, indicating that expo-
sure to PDTC disrupted the assembly of transcription factors
binding to this region of the HGF gene (Fig. 2b).
We analysed the sequence of the HGF promoter region be-
tween 75 and +42 bp to identify possible transcription factor
binding sites (MatInspector, Genomatix [29]), which are
Fig. 1. Eﬀect of PDTC on HGF mRNA and protein expression in MRC-5 cells. Total RNA was isolated from MRC-5 cells and 30 lg subjected to
sequential Northern blot analysis using: a 32P-labelled 668 bp HGF cDNA probe, 40 h autoradiographic exposure; and a 32P-labelled GAPDH cDNA
probe, as a loading control, 6 h autoradiographic exposure. (a)MRC-5 cells were exposed to increasing concentrations of PDTC for 24 h (left panel) or
500 lM PDTC for up to 24 h (right panel). MRC-5 cells were cultured for 24 h with (b) PMA (top panel) or IL-1b (bottom panel) or (c) NAC, in the
presence or absence of 500 lMPDTC. (d)MRC-5 cells were exposed to 500 lMPDTC for 6 h andRNA isolated at time points after the addition of 5 lg/
ml actinomycin-D. (e) MRC-5 cells were cultured under the same conditions as for the Northern blot analysis and exposed to increasing concentrations
of PDTC for 3 days. HGF levels in the conditioned media were measured by ELISA (left panel) and scatter factor assay [25] (right panel).
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factors binding to this region is known to be regulated byPDTC or to interact with known PDTC-regulated DNA bind-
ing proteins, such as AP-1 or NF-jB.
Fig. 2. Activity of human HGF promoter-CAT chimeric genes and electrophoretic mobility shift assay. (a) NIH3T3 ﬁbroblasts were transfected with
HGF-CAT chimeric reporter gene constructs by the calcium phosphate method and exposed to 500 lM PDTC for 24 h. After adjustment for
transfection eﬃciency, standard CAT assay was performed. CMV-CAT and pCAT-basic were used as controls. Each result is the median of four
assays. (b) Electrophoretic mobility shift assay was used to demonstrate complex formation between the HGF promoter and nuclear proteins in
control and PDTC treated MRC-5 cells. The DNA probe used was the 75 to +42 bp HGF promoter sequence labelled with c32P-dATP. Lanes 1–4,
nuclear protein in control MRC-5 cells: lane 1, no competitor; lane 2, unlabelled HGF (75/+42 bp) competitor probe; lane 3, unlabelled non-speciﬁc
competitor probe, E3; lane 4, unlabelled competitor probe, AP-1; lane 5, nuclear protein in PDTC treated MRC-5 cells, no competitor probe. The
speciﬁc (displaceable) and non-speciﬁc (non-displaceable) nuclear protein–DNA complexes are indicated by arrows. (c) Analysis of the HGF
promoter region between 75 and +42 bp identifying putative transcription factor binding sites (MatInspector, Genomatix [29]).
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The present study demonstrates that PDTC is a potent
inhibitor of basal and induced HGF gene expression in
MRC-5 cells resulting in a marked down-regulation of HGF
mRNA, in a dose and time-dependent manner. Consequently,
HGF protein production by MRC-5 cells was signiﬁcantly
inhibited by all doses of PDTC tested. This is the ﬁrst study
to our knowledge to describe a small molecule inhibitor of
HGF expression.
PDTC is known to regulate the expression of several genes
by modulating the activity of transcription factors. It inhibitsthe DNA binding activity of NF-jB, by preventing the degra-
dation of IjB alpha via the ubiquitylation-proteasome proteo-
lytic pathway [30], and of Nuclear Factor of Activated T cells
(NFAT), by a mechanism dependent on the stimulation of
tyrosine kinase pathways [31]. PDTC also activates AP-1 activ-
ity by modulating expression of c-jun and c-fos [32] and Nrf2
DNA binding complexes, containing either JunD or small Maf
protein [33]. We analyzed the sequence of the promoter region
between 75 and +42 bp to identify potential transcription
factor binding sites (MatInspector, Genomatix [29]) but none
of the candidate transcription factors binding in this region
of the HGF gene, HOXA9, RORA2, OCT1 or HOXC13, is
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regulated DNA binding protein. AP-1 does not appear to reg-
ulate this region of the HGF gene, as a probe containing a con-
sensus AP-1 recognition sequence failed to block binding of
the nuclear proteins to the HGF promoter. Nevertheless, we
identiﬁed three speciﬁc protein/DNA complexes that bound
between 75 and +42 in the 5 0-ﬂanking region of the HGF
gene and these were lost when the MRC-5 cell were exposed
to PDTC, suggesting that PDTC exposure disrupts the assem-
bly of the basal transcription apparatus of the HGF gene.
However, to date we have not been able to characterize the se-
quence of the PDTC response element in the human HGF pro-
moter or to conﬁrm the transcription factors abrogated by
PDTC.
In summary, we show that PDTC inhibits not only innate
HGF gene expression in MRC-5 cells but also the up-regula-
tion of HGF mRNA induced by several well-characterized fac-
tors, acting via diﬀerent mechanisms. Furthermore, we
demonstrate that PDTC acts by disrupting the assembly of
transcription factors to the region of the HGF gene ﬂanking
the transcription initiation site. Previous reports have demon-
strated that dithiocarbamates protect the liver from N-nitro-
sodiethylamine-induced tumour development [34] and inhibit
the growth of colon cancer cells in mice [35]. PDTC is an orally
active, small molecule and, based on the ﬁndings of the present
study, further work is needed to investigate whether it can in-
hibit the growth of HGF-dependent tumour cells.
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